SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 3/31/06 Nanobac Pharmaceuticals Inc 10KSB 12/31/05 7:2.2M Vintage/FA |
Document/Exhibit Description Pages Size 1: 10KSB Annual Report -- Small Business HTML 764K 2: EX-10.26 Material Contract HTML 5K 3: EX-21.1 Subsidiaries of the Registrant HTML 7K 4: EX-31.1 Certification per Sarbanes-Oxley Act (Section 302) HTML 15K 5: EX-31.2 Certification per Sarbanes-Oxley Act (Section 302) HTML 15K 6: EX-32.1 Certification per Sarbanes-Oxley Act (Section 906) HTML 8K 7: EX-32.2 Certification per Sarbanes-Oxley Act (Section 906) HTML 8K
(a)
|
Designed
such disclosure controls and procedures or caused such disclosure
controls
and procedures to be designed under my supervision, to ensure that
material information relating to the Registrant including its consolidated
subsidiaries, is made known to us by others within these entities,
particularly during the period in which this report is being
prepared;
|
(b)
|
Evaluated
the effectiveness of the Registrant’s disclosure controls and procedures
and presented in this report our conclusions about the effectiveness
of
the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and
|
(c)
|
Disclosed
in this report any change in the Registrant’s internal control over
financial reporting that occurred during the Registrant’s most recent
fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely
to
materially affect, the Registrant’s internal control over financial
reporting; and
|
(a)
|
All
significant deficiencies in the design or operation of internal controls
over financial reporting which are reasonably likely to adversely
affect
the Registrant’s ability to record, process, summarize and report
financial data information; and
|
(b)
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the Registrant’s internal
controls over financial reporting.
|
|
|
|
Date: March 30, 2006 | By: | /s/ John D Stanton |
John D Stanton |
||
Chief Executive Officer |
This ‘10KSB’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/31/06 | 10QSB | ||
3/30/06 | 8-K | |||
For Period End: | 12/31/05 | |||
List all Filings |